Related Experiment Video
Updated: Jul 17, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Peripartum cardiomyopathy.
Miguel A Rodríguez-González1, Arturo Medina-Ruíz
1Cardiology Section, Internal Medicine Department, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Puerto Rico Health Sciences Journal
|January 6, 2007
Summary
Peripartum cardiomyopathy (PPCM) is a heart muscle condition affecting women late in pregnancy or postpartum. Despite current treatments, PPCM still has high mortality rates, highlighting the need for more research.
Area of Science:
- Cardiology
- Maternal-Fetal Medicine
- Heart Failure Research
Background:
- Peripartum cardiomyopathy (PPCM) affects women of reproductive age during late pregnancy or postpartum.
- The exact cause of PPCM remains unknown, despite identified risk factors and etiological hypotheses.
- Current PPCM treatment follows standard heart failure protocols.
Purpose of the Study:
- To review current knowledge on the etiology, diagnosis, treatment, and prognosis of PPCM.
- To identify areas requiring further research in PPCM management and understanding.
Main Methods:
- Literature review of existing studies on Peripartum cardiomyopathy.
- Synthesis of current data on PPCM etiology, diagnosis, and treatment.
- Analysis of PPCM prognosis and mortality rates.
Main Results:
- PPCM diagnosis and treatment align with general heart failure guidelines.
- Emerging therapeutic strategies are expanding treatment options for PPCM.
- Despite advancements, Peripartum cardiomyopathy is associated with high mortality rates.
Conclusions:
- Further research is crucial to elucidate PPCM etiology and improve patient outcomes.
- Enhanced understanding and novel therapies are needed to reduce PPCM-related mortality.
- Optimizing Peripartum cardiomyopathy diagnosis and treatment remains a significant clinical challenge.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...